Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1

The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies, MD, PhD, Professor and Chairman of the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center, recently chaired i3 Health’s CME/NCPD/AAPA activity, "Melanoma in Minutes: Evidence-Driven Care for Improved Patient Outcomes." With numerous new developments in melanoma treatment over recent months, Dr. Davies sat down again to share these critical updates that are impacting practice. After the interview, stay tuned to hear module 1 of the full podcast activity. Click the link to complete module 1 and claim your free credit: bit.ly/4iYmYD2

You can listen to Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1 online on Radio and Podcast. Open the player on this page to stream the available audio.

Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1 is an episode from Oncology Data Advisor by Oncology Data Advisor™.

This episode is 00:56:43 long.

This episode was published on Jan 27, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Data Advisor when more episodes are available from the podcast feed.